These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 7638743)
1. Administration of anti-CD4 monoclonal antibody with intrathymic injection of alloantigen results in rat cardiac allograft tolerance. Arima T; Goss JA; Walp LA; Flye MW Surgery; 1995 Aug; 118(2):265-72; discussion 272-3. PubMed ID: 7638743 [TBL] [Abstract][Full Text] [Related]
2. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen. Arima T; Lehmann M; Flye MW Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332 [TBL] [Abstract][Full Text] [Related]
4. MHC class II presenting cells are necessary for the induction of intrathymic tolerance. Goss JA; Nakafusa Y; Flye MW Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312 [TBL] [Abstract][Full Text] [Related]
5. Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration. Motoyama K; Arima T; Lehmann M; Flye MW Surgery; 1997 Aug; 122(2):213-9; discussion 219-20. PubMed ID: 9288125 [TBL] [Abstract][Full Text] [Related]
6. Prevention by thymectomy of tolerance induced by intrathymic injection of donor splenocytes. Nakafusa Y; Goss JA; Flye MW Surgery; 1993 Aug; 114(2):183-9; discussion 189-90. PubMed ID: 8342124 [TBL] [Abstract][Full Text] [Related]
7. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration. Motoyama K; Arima T; Yu S; Lehmann M; Flye MW Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640 [TBL] [Abstract][Full Text] [Related]
19. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration. Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539 [TBL] [Abstract][Full Text] [Related]
20. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide. Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]